Table 5.
CAM use by African Americans with RA participating in the CLEAR Registry at enrollment*
| CAM use | Overall (n = 855) |
Disease duration |
Sex |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Longer, >2 yrs (n = 437) |
Early, <2 yrs (n = 418) |
P † | Univariate OR (95% CI)† |
Women (n = 726) |
Men (n = 129) |
P † | Univariate OR (95% CI)† |
||
| Treatment‡ | |||||||||
| Ever | 812 (95.0) | 418 (95.7) | 394 (94.3) | 0.35 | 1.3 (0.7–2.5) | 692 (95.3) | 120 (93.0) | 0.27 | 1.5 (0.7–3.3) |
| Past month | 626 (73.2) | 322 (73.7) | 304 (72.7) | 541 (74.5) | 85 (65.9) | ||||
| Activity§ | |||||||||
| Ever | 839 (98.1) | 434 (99.3) | 405 (96.9) | 0.01¶ | 4.6 (1.3–16.4)¶ | 714 (98.4) | 125 (96.9) | 0.28 | 1.9 (0.6–6.0) |
| Past month | 830 (97.1) | 430 (98.4) | 400 (95.7) | 707 (85.2) | 123 (95.4) | ||||
| Provider# | |||||||||
| Ever | 438 (51.2) | 223 (51.0) | 215 (51.4) | 0.91 | 1.0 (0.8–1.3) | 371 (51.1) | 67 (51.9) | 0.86 | 1.0 (0.7–1.4) |
| Past 6 months | 274 (32.0) | 119 (27.2) | 155 (37.1) | 233 (32.1) | 41 (31.8) | ||||
*
Values are the number (percentage) unless indicated otherwise. CAM = complementaryand alternative medicine; RA = rheumatoidarthritis; CLEAR = Consortiumfor the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis; OR = oddsratio; 95% CI = 95% confidence interval.
†
By logistic regression.
‡
Used at least 1 of the 16 treatments.
§
Used at least 1 of the 9 activities.
¶
Statistically significant at the 0.05 level.
#
Consulted at least 1 of the 5 CAM providers.